US equities
|
MU
$1,088.00
▲+0.00%
SNDK
$1,692.42
▲+0.00%
NVDA
$237.47
▲+0.00%
INTC
$113.12
▲+0.00%
AMD
$645.86
▲+0.00%
MSTR
$153.37
▲+0.00%
SPCX
$167.60
▲+0.00%
SKHY
$178.25
▲+0.00%
MU
$1,088.00
▲+0.00%
SNDK
$1,692.42
▲+0.00%
NVDA
$237.47
▲+0.00%
INTC
$113.12
▲+0.00%
AMD
$645.86
▲+0.00%
MSTR
$153.37
▲+0.00%
SPCX
$167.60
▲+0.00%
SKHY
$178.25
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Cosmo Feilding Mellen
Recent news which mentions Cosmo Feilding Mellen
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
M&A
Eleusis
Shlomi Raz
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
Benzinga
Financing
Tim Schlidt
From
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Tickers
CLABF
MYCOF
SILFF
Tags
Diamond Therapeutics Inc/
Benzinga
Cosmo Feilding Mellen
From
Benzinga